Murine Spinal Cord Transcriptome Analysis Following
Reduction of Prevalent Myelin cDNA Sequences
Yan, Zhi; Lathia, Kanan B., Clapshaw, Patric A. 1
Solomon Park Research Institute,
SUMMARY
From 1000 randomly selected colonies from cDNA libraries derived from murine spinal cord subtracted against white matter by means of suppression subtractive hybridization, 220 clones were identified as differentially expressed by dot blot analysis. Sequence analysis by the BLAST programming identified 140 unique genes.
The current study demonstrates the importance of reducing the presence of glial associated sequences when comparing brain regions.
It is concluded that the persistence of some myelin sequences in the spinal cord when white matter is used as the driver indicates that myelination is more active in this structure than for those areas represented by white matter and corpus callosum.
Key Words: spinal cord transcriptome, suppression subtractive hybridization, glia, white matter, motor neuron disease
1 Author to whom inquiries concerning this article should be made. Email pclapshaw@solomon.org
INTRODUCTION
Using suppression subtraction hybridization (SSH) (Diatchenko et al. 1996) and mirror orientation selection (MOS) (Rebrikov et al. 2000), we have previously demonstrated that a number of genes are differentially expressed in murine spinal cord without sensory ganglia when subtracted against the visual cortex, a motor neuron poor area of the brain (Lathia et al, 2006). A large percentage of these differentially expressed genes (44 percent) are of known glial origin; primarily proteolipid protein (Plp1), ferretin heavy chain (Fth1) and myelin basic protein (Mbp) among others. Similar results are reflected in the expression profiles for many myelin genes in the murine spinal cord in the expressed sequence tag database (dbEST) held at the NCBI UniGene project (Pontius et al. 2003).
Subtraction of any brain area against any other brain area including the spinal cord would necessarily include a large amount of myelin which should subtract out as a common element. It seems unlikely, therefore, that glial sequences are being expressed in the spinal cord merely as a result of an overabundance of glia in this structure. The amount of various myelin proteins; proteolipid protein (PLP), myelin basic protein (MBP) and 2’, 3’ cyclic nucleotide 3’ phosphodiesterase (CNP) are not increased in spinal cord over that of other brain areas in human tissue (Trotter et al. 1984), however, the prospect that glial proteins are continuing to be produced in the spinal cord after significant turnover has slowed in other areas of the nervous system cannot be ruled out.
It is possible that our results, as well as previous attempts by others to demonstrate differences between areas in the nervous system (Kobayashi et al 1991; Usui et al. 2003; Akopian and Wood, 1995; de Chaldée et al. 2003 and Sandberg et al. 2000), record small differences between these structures because of the overwhelming presence or activity of glial elements co-expressing and obscuring the less abundant neural elements.
In an attempt to reduce the presence of glial derived sequences, we used spinal cord as the tester and isolated white matter as driver and vice versa in the present study in order to examine the spinal cord transcriptome. A continued presence of a significant number of glial derived genes differentially expressed in the spinal cord would indicate that myelination or other glial activities are increased over other brain areas tested in the adult mouse.
MATERIALS AND METHODS
Tissue Preparation
Tissues for all
subtractions were from 90-110 day old male C57Bl6J mice housed at the Jackson
Laboratories in
RNA Isolation
Total RNA was isolated by the method of Chomczynski & Sacchi (1987). Messenger RNA was further isolated on poly T columns purchased from Ambion.
Suppression Subtractive Hybridization
Suppression subtractive hybridization was performed using The BD Clontech PCR-Select™ cDNA Subtraction Kit with cDNA from spinal cord as tester and cDNA from white matter as driver or vice versa in reverse subtractions. cDNA from each specimen was prepared from 2 µg Poly (A)+. RNA preparations were digested with the endonuclease RSA 1. Tester cDNA were then divided into 2 subpopulations and each ligated with either adaptor 1 or adaptor 2R from Clontech. Subtractions and normalizations were accomplished with a 50 fold excess of driver over tester followed by 2 rounds of PCR amplification. Subtraction efficiency was measured by the intensity of the PCR products on agarose gel representing glucose 3 phosphodiesterase before and after the SSH procedure.
Transformation
Secondary PCR products were transformed into pCR® 4-TOPO vector with TOP10 E. coli cells (InVitrogen).
Probe preparation
Approximately twenty five nanograms of secondary PCR products from forward and reverse subtractions were labeled using 50uCi of [32p] dCTP with Rediprime II Random Prime Labeling System from Amersham. Labeled probes were purified using BD Chroma Spin Columns from BD Biosciences
Differential Screening
Differential screening was performed by dot blot analysis using the PCR-Select Differential Screening Kit from BD Biosciences. Identical sets of subtracted clones were spotted onto four nylon transfer membranes (Schleicher and Schuell). The membranes were subsequently interrogated with [32P] labeled cDNA (RediprimeII random prime labeling system from Amersham Biosciences) from the forward and reverse subtracted and unsubtracted probes. Clones exhibiting at least two fold differences only in the forward subtraction were included in the subtracted library.
Sequencing
Sequences from
secondary PCR products were obtained from Retrogen in
Northern Hybridization Procedure
Total RNA (50µg) from murine spinal cord, or white matter was separated by gel electrophoresis on 1% agarose – formaldehyde gel using the northernMax Kit from Ambion and subsequently blotted onto a nylon hybridization membrane from Ambion. Custom primers were synthesized and subsequently, amplified and purified from low melting gels using Qiaquick gel purification kit from Qiagen.
Comparison of Current Results with
UniGene Records
All genes exhibiting higher expression in the spinal cord were compared to the UniGene entries listed at the NCBI open access data base for Mus musculus at (http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=unigene). All sequences were scored with the estimated number of sequences per million. Sequences marked with a double dagger (‡) represent sequences that were the top three most frequent in the spinal cord for these genes. Sequences that were not found in the murine spinal cord in UniGene even though measured were marked as zero. Sequences not previously measured in the murine spinal cord as well as ESTs never before reported are marked in the tables as [no data]. UniGene data were current as of March 31, 2007.
RESULTS
Overall Analysis of Differentially
Expressed Sequences
Approximately 1,000 colonies across 3 separate subtractions of spinal cord subtracted against white matter, were randomly selected for analysis. Two hundred and twenty clones from these colonies were identified by dot blot analysis as differentially expressed in spinal cord and subsequently sequenced and identified using the basic local alignment and search tool (BLAST) programming available through the NCBI. From these, 140 unique genes were identified. The results of these subtractions are summarized in table I (A-F) along with the current estimate of sequences per million for each identified EST in the UniGene database. Protein products were classified from either Entrez Online Mendelian Inheritance in Man (OMIM) at (http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=OMIM), Entrez Gene at (http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene ), Entrez Protein at (http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=Protein) or from Pubmed at (http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed ).
See Table I A-F
Dot Blot Analysis of Differentially
Expressed Sequences
A representative dot blot analysis is shown in figure 1. Approximately 50 percent of the cloned sequences show increased labeling. The labeled samples were scored and only those represented by at least a two fold increase in labeling intensity when tested by the forward subtracted probe versus forward unsubtracted and reverse subtracted and unsubtracted probes were selected for inclusion in the subtracted library.
Northern Analysis of Differentially
Expressed Sequences
All sequences used in the northern analyses were selected from dot blot confirmed, differentially hybridized libraries. These northern analyses are shown in figure 2. All colonies used were randomly drawn from one of three categories from the UniGene database held at the NCBI. The first category represents genes that are not yet documented in murine spinal cord: secreted phosphoprotein 1-osteopontin (Spp1), myelin protein zero (Mpz) and RIKEN cDNA 111000P04 (111000P04Rik). The second category is moderately represented in spinal cord (RIKEN cDNA 4732416N19 (4732416N19Rik), peripheral myelin protein 22 (Pmp22), flotillin 2 (Flot2) and ATPase, Na+/K+ transporting alpha 2 polypeptide (Atp1a2). The third category is from genes that are highly represented in spinal cord: Glial fibrillary acidic protein (Gfap), kallikrein 6 (Klk6), neurofilament heavy chain (Nefh) and neurofilament medium chain (Nefm). The increase in labeling for all genes is substantial with the exception of Flot2 which shows an approximately 50 percent increase by density scanning (data not shown) in spinal cord versus white matter. The Northern blots representing these sequences were normalized with β actin as shown in the figure.
Differential Expression of Myelin
Associated Sequences
Eighteen clones representing nine known, unique myelin associated sequences were differentially expressed in spinal cord when subtracted against white matter and represent 10 percent of all clones in this subtraction as represented in Table II. Entries marked with the double dagger (‡) are expressed among the top three most frequently represented in spinal cord in the UniGene database.
The number of clones represented by all known glial cell derived sequences is reduced from 44 percent when spinal cord was subtracted against visual cortex in our previous study to 10 percent when this structure is subtracted against isolated white matter. The number of clones represented by Plp1 was
Fig. 1 Representative Dot Blot Analysis
dot blot analyses of four identical membranes spotted with 1uL of PCR product from individual bacterial colonies transformed with cDNA from forward suppression subtractive hybridization (SSH). Each membrane was subsequently hybridized with the following probes:
Forward Subtracted signifies cDNA derived from spinal cord as tester and white matter as driver
Forward Unsubtracted signifies cDNA derived from spinal cord before subtraction against white matter.
Reverse Subtracted signifies cDNA derived from white matter as tester and spinal cord as driver.
Reverse Unsubtracted signifies cDNA derived from white matter before subtraction against spinal cord.
Clones are considered to be representative of cDNA sequences differentially expressed only if the density of labeling in the forward subtracted condition is at least twice that of any other condition.
reduced from 22 percent in our previous study (spinal cord subtracted against visual cortex) to less than one percent in the present study.
See Table II
White Matter Subtracted Against Spinal
Cord
Three hundred colonies across two separate subtractions where myelin was subtracted against spinal cord (reverse subtraction) were tested for differential expression by dot blot analysis. Out of 56 differentially expressed clones, 28 were sequenced and of these, 18 were unique and are listed in table III. The genes found to be differentially expressed in isolated brain white matter when this material was subtracted against spinal cord contained no known myelin specific genes.
See Table III
Novel Expressed Sequences not Represented by mRNA
Sequences
Four of the ESTs in the present study differentially expressed in spinal cord (NCBI accession numbers ES387449, ES387454, ES387457 and ES387458) are novel and have been recorded in the NCBI database.
Expressed Sequence not previously measured in murine
spinal cord
One of the ESTs in the present study, suppressor of lin-12 1 homolog (C. elegans), Sel1h, although adequately represented with numerous ESTs has not been measured in the mouse spinal cord to date and therefore has no entry in the UniGene database for this structure.
DISCUSSION
General Considerations
The complexity of the transcriptome of any nervous system is enormous. This is especially evident in mammalian nervous systems where the number and variety of neurons is most probably at least in the hundreds if not the thousands, each contributing an array of messenger RNA molecules to the overall transcription occurring in the system at any particular time (Stevens 1998; MacNeil et al.1999). Adding to the difficulty of obtaining any meaningful information from individual neurons in such a system is the large number of glial cells outnumbering neurons by at least ten and possibly a hundred fold in some areas.
Various techniques have been developed over the past several years that allow the transcriptomes of either individual cells or tissues or whole organs to be analyzed for mRNA presence and abundance. The most widely used of these methods are laser capture (Emmert-Buck et al., 1996) for the isolation of mRNA from individual cells, (however see Kodha et al. 2000), microarray technology (Schena et al. 1995); serial analysis of gene expression (SAGE) (Velculescu et al. 1995) and subtractive hybridization (Hedrick et al. 1984) with a number of other techniques derived from these basic procedures for populations of cells. Suppression subtractive hybridization (SSH) alone simultaneously allows both the direct comparison of two tissues and the detection of rare or low abundance as well as unknown transcripts (Shusta, 2005).
By subtracting spinal cord directly against isolated white matter, we have eliminated nearly three quarters of the known glial sequences previously documented by us in subtractions against visual cortex containing underlying white matter. Using isolated myelin as driver allows us to identify an array of differentially expressed genes more consistent with the neural elements making up this structure.
Comparison to UniGene Results
There is a good correlation with our approach to the data already accumulated from many sources for the spinal cord as represented by the UniGene dbEST expression profiles. Approximately one in every three of our clones (49 out of 140) is represented by sequences that are among the highest in frequency in the existing dbEST data for spinal cord. More significantly, nearly an equal number (45 out of 140), although sought, have never been detected in the spinal cord as represented by the same database. Eight percent (4 out of 211) are new ESTs that have not been demonstrated in the mouse to date. In total, 49 of the 140 differentially expressed genes or 35% have not been shown to be expressed in the spinal cord to date indicating that a large percentage of genes differentially expressed in this structure are unreported.
Specific Observations concerning
Differentially Expressed genes
The spinal cord subtracted against isolated myelin shows many differentially expressed sequences (24 per cent) representing proteins concerned with structural and motor activities involved with maintaining and transporting molecules and organelles along the extended axons known to be present in this structure. The next largest portion (27 per cent) are sequences representing enzymes, a large portion of these (8 per cent of the total number of differentially expressed genes) are concerned with either glycolysis or lipid metabolism. A number of genes representing ion channels and other uptake functions are well represented as might be expected for the spinal cord neural population.
The strong showing of Spp1 (osteopontin) as well as Sparc (osteonectin) deserves some mention. We have also observed these two genes differentially expressed when we subtracted spinal cord against visual cortex (Lathia et. al., 2006). Neither of these genes is recorded as differentially expressed in the spinal cord in the UniGene database. One explanation for these genes being differentially expressed is their correlation with growth factors such as connective tissue growth factor (Denhardt & Noda 1998, Rittling & Denhardt 1999) which again should be expected in the spinal cord.
Leucyl t-RNA synthetase (Lars2) is strongly differentially expressed in the spinal cord. This is a verification of our previous subtractions of spinal cord against visual cortex. In the present study, Lars2 represents 12 percent of the total clones differentially expressed and was eight percent of the total number of clones when subtracted against visual cortex. No other aminoacyl t-RNA synthetase is represented in either subtraction. The aminoacyl t-RNA synthetases are known to be phylogenetically old and as such it is speculated that a number of these proteins may have evolved alternate roles (Martinis, S.A. et al., 1999). It is known, for example, that human cytoplasmic tRNA synthetases are assembled into large macromolecular complexes during protein synthesis which masks any alternate functions concerned with the immune response, apoptosis and angiogenesis (Wakasugi et al. 1999 and Wakasugi et al. 2002). In microorganisms, leucyl-tRNA synthetases have been show to facilitate RNA splicing activities (Houman et al. 2000). Finally, Lars2 also has been shown to have a critical amino acid proofreading activity to ensure the fidelity of protein synthesis (Karkhanis et al. 2006).
When we reversed our subtraction and subtracted white matter from spinal cord, we found no known myelin or glial associated genes differentially expressed, strongly indicating that the presence of differentially expressed sequences in the spinal cord represent genes that are truly differentially expressed and not simply the product of an excessive amount of glial derived sequences.
At the age that the animals were tested (90-110 days), it is generally assumed that the formation of myelin has been completed. The persistence of genes associated with myelin in adult murine spinal cord when subtracted against white matter can best be explained by assuming that the spinal cord is simply exhibiting higher rates of myelin production or metabolism than the other brain areas measured at this age. The driver cDNA, in this case the underlying white matter from all areas of the cerebral cortex, presents sufficient cDNA from myelin to subtract out any cDNA from glial cells in the spinal cord.
Our results also confirm that SSH represents the best approach to elucidating the transcriptomes of nerve cells isolated from the overwhelming influence of the surrounding glial cells. The large number of genes differentially expressed in our study which are recorded as not present in the spinal cord by the large dbEST indicates that a significant percentage (nearly a third) of differentially expressed genes are being unreported by most studies.
By selecting the appropriate driver and tester in the subtraction not only can the background of myelin be greatly reduced or eliminated, but sub classes of neurons can be subtracted against each other eventually allowing a single cell type to be analyzed. The only viable alternative to this would be an isolation of single cells directly and although technically possible this procedure presents problems not only in the length of time that is required to fix and mechanically isolate the cells, but also in that the amount of RNA ultimately achieved is small and the amplification of these sequences is known to introduce significant artifacts into the final analysis (Nygaard et al. 2005). SSH on the other hand represents a rapid and sensitive procedure for quantifying transcription events in the nervous system, however, it should be noted that all procedures necessarily take some time to extract and process the tissues of interest leaving the possibility that some genes may be differentially expressed due to extraneous variables.
Finally, the persistence of myelin associated sequences in the spinal cord raises the possibility that diseases that preferentially affect this structure, such as motor neuron disease, can do so through these cells. It is obvious that the extended structural demands of motor neurons as well as their enormous energy requirements and the known uptake and processing of neurotransmitters by surrounding cells, make the nerve cells served by these glial cells in the spinal cord potentially vulnerable to many insults from within.
CONCLUSION
When adult, murine spinal cord is subtracted directly against isolated white matter and corpus callosum, the number of myelin associated genes differentially expressed in this structure is reduced but not eliminated from that seen in previous studies where spinal cord was subtracted against visual cortex with underlying white matter. Myelination or myelin associated activity is clearly differentially expressed in spinal cord, complicating attempts to view the transcriptomes of neural elements in this structure. Comparison of these results with established expression databases indicates that large numbers of genes are not being reported.
ACKNOWLEDGMENTS
This
work is supported by a bequest from the estate of
We are especially appreciative of the many helpful remarks and suggestions from Dr. Susan A. Martinis concerning the role of leucyl-tRNA synthetase.
REFERENCES
Akopian, A.N., and Wood,
J.N. Peripheral nervous system-specific genes identified by subtractive cDNA
cloning. JBC (1995) 270 (36) 21264-21270.
Chomczynski, P., and
Sacchi, N. Single-step Method of RNA Isolation by Acid Guanidinium
Thiocyonate-Phenol-Chloroform Extraction, Anal.
Biochem. (1987) 162, 156.
De
Chaldee, M., Gaillard, M-C., Bizat, N., Buhler, J-M., Manzoni, O., Bockaert,
J., Hantraye, P., Brouillet, E. and Elalouf, J-M. Quantative assessment of
transcriptome differences between brain territories. Genome Research (2003) 13
1646-1653.
Denhardt, D.T. and Noda,
M. Osteopontin expression and function:
role in bone remodeling.
Journal of Cellular Biochemistry (1998) 30–31
(Suppl) 92–102.
Diatchenko L, Lau
Y, Campbell A, Chenchik A, Moqadam F, Huang B, Lukyanov S, Lukyanov K, Gurskaya
N, Sverdlov E, Siebert P (1996). Suppression subtractive hybridization: a
method for generating differentially regulated or tissue-specific cDNA probes and libraries.
Proc Natl Acad Sci U S A 93 (12): 6025-30.
Emmert-Buck,
M.R.; Bonner, R.F.; Smith, P.D.; Chuaqui, R.F.; Zhuang, Z.; Goldstein, S.R.;
Weiss, R.A. and Liotta, L.A. (1996)
Laser Capture Microdissection Science 274(5289):998-1001
Hedrick, S.M.,
Chen, D.I., Nielsen, E.A., and
Houman,
F., Rho, S.B., Zhang, J., Shen, X., Wang, C.-C., Schimmel, P., and
Martinis, S.A. (2000) A Prokaryotic and Human tRNA Synthetase
Provide an Essential RNA Splicing Function in Yeast Mitochondria. Proc.
Natl. Acad. Sci.,
Karkhanis,
V.A., Boniecki, M.T., Poruri, K ., and Martinis,
Kobayashi,
H., Takahashi, H., Oyanagi, K., Ikuta, F., Miyatake, T., and Tsuji, S.
Construction of Spinal Cord cDNA library and application for subtractive
cloning of spinal cord-specific cDNAs. J. Mol. Neurosci. (1991) 3:59-64.
Kohda, Y.; Murakami, H.; Moe,
O.W. and Star, R.A. (2000) Analysis of segmental renal gene expression by laser
capture microdissection. Kidney International Vol. 57 pp 321-331
Lathia, K.B.,
Yan, Z., and Clapshaw, P.A. (2006) Spinal Cord Transcriptome Analysis Using
Suppression Subtractive Hybridization and Mirror Orientation Selection. Cell.
Mol. Neurobiol. 26(3):259-75.
MacNeil, M.A. and
Masland, R.H. (1998) Extreme diversity among amacrine cells: Implications for
function. Neuron 20:971-982.
Martinis,
Nygaard,
V., Holden, M., Løland, A., Langaas, M., Myklebost, O. & Hovig, E. (2005)
Limitations of mRNA amplification from small-size cell samples. BMC Genomics
6:147 Published online 2005 October 27. doi: 10.1186/1471-2164-6-147.
Pontius,
J.U., Wagner, L., Schuler, G.D. (2003) UniGene: a unified view of the
transcriptome. In: The NCBI Handbook.
Rebrikov,
D.V., Britanova, O.V., Gurskaya, N.G., Lukyanov, K.A., Tarabykin, V.S. and
Rittling, S.R.and
Denhardt, D.T. Osteopontin function in pathology:
lessons from
osteopontin-deficient mice. Experimental Nephrology (1999) 7
103–113.
Sandberg,
R., Yasuda, R., Pankratz, D.G.; Carter, T.A.,
Schena M, Shalon
D, Davis RW, Brown
Shusta, E.V. (2005)
Blood-Brain Barrier Genomics, Proteomics, and New Transporter Discovery.
NeuroRx Vol. 2, No. 1. pp 151-61.
Stevens C.F.
(1998)Neuronal diversity: too many cell types for comfort? Curr Biol.
8(20):R708-10
Trotter, J.L.,
Wegescheide, C.L., and Garvey, W.F. (1984) Regional studies of myelin proteins
in human brain and spinal cord. Neurochem.
Res. 9(1):133-146
Usui,
H., Falk, J.D., Dopazo, A., de Lecea, L., Erlander, M.G. and Sutcliffe, J.G.,
Isolation of clones of rat striatum-specific mRNAs by directional Tag PCR
subtraction. J. Neurosci. (1994) 14(8)
4915-4926.
Velculescu VE,
Zhang L, Vogelstein B, and Kinzler KW. (1995) Serial Analysis of Gene
Expression. Science 270:484-7
Wakasugi, K. and
Schimmel, P. (1999). Two distinct cytokines released from a human aminoacyl
tRNA synthetase. Science 284: 147-151.
Wakasugi, K.,
Slike, B., Hood, J., Otani, A., Ewalt, K. L., Friedlander, M., Cheresh, D. A.,
and Schimmel, P. (2002). A human aminoacyl-tRNA synthetase as a regulator of
angiogenesis. Proc. Natl. Acad. Sci. USA 99: 173-177).
Huminiecki L, Lloyd AT, Wolfe
KH. (2003)Congruence of tissue expression profiles from Gene Expression Atlas,
SAGEmap, and TissueInfo databases. BMC Genomics 4:31.
TABLES AND FIGURES
TABLE I
GENE SEQUENCES DIFFERENTIALLY
EXPRESSED
IN
SPINAL CORD VERSUS WHITE MATTER
|
Table I Gene Sequences Differentially
Expressed in Spinal Cord versus White Matter |
|||
|
Table I -A Structural and Motor Protein Sequences |
|||
|
Gene Abbreviation |
Gene Frequency |
UniGene Frequency |
Putative and Known Functions |
|
Spp1 |
5 |
0 |
bone
structure osteoclasts (osteopontin) |
|
Mpz |
3 |
0 |
myelin adhesion protein (Schwann Cells) |
|
Myo5a |
2 |
0 |
motor
activity (centriole) |
|
Elmod2 |
1 |
0 |
cytoskeleton |
|
Mast1 |
1 |
0 |
motor
microtubule activity |
|
Tnni2 |
1 |
0 |
muscle
contraction |
|
Ttn |
1 |
0 |
muscle
structure and function |
|
Anln |
1 |
37 |
cytoskeleton
(actin binding) |
|
Nebl |
1 |
37 |
cytoskeleton
(actin binding) |
|
Sparc |
2 |
75 |
bone structure
osteoclasts (osteonectin) |
|
Kif5c |
1 |
75 |
motor
axon trafficking |
|
Scg3 |
1 |
75 |
muscle
actin binding sarcolemma |
|
Ankfy1 |
1 |
75 |
trafficking
vesicle |
|
Sept8 |
1 |
75 |
trafficking
vesicle/neuronal polarity |
|
Rer1 |
1 |
75 |
trafficking
Golgi |
|
Kif5b |
2 |
150 |
motor
microtubule activity |
|
Ap3m1 |
1 |
150 |
clathrin
binding |
|
Dynll2 |
1 |
187 |
motor
microtubule activity |
|
Gfap |
3 |
112‡ |
myelin intermediate filaments (oligodendroglia) |
|
Nefh |
4 |
187‡ |
cytoskeleton
(neural) |
|
Ap1m1 |
2 |
225‡ |
clathrin
binding |
|
Lrpprc |
1 |
225‡ |
cytoskeleton
with vesicular trafficking |
|
Nefm |
4 |
300‡ |
cytoskeleton
(neural) |
|
Plp1 |
2 |
712‡ |
myelin sheath |
|
Mbp |
1 |
2026‡ |
myelin sheath |
|
Total |
44 |
|
25 Unique genes |
|
Table I -B Receptor and Binding Protein Sequences |
|||
|
Gene Abbreviation |
Gene Frequency |
UniGene Frequency |
Putative and Known Functions |
|
Il6st |
1 |
0 |
cytokine
receptor (including CNTF) |
|
Lgals8 |
1 |
0 |
lectin
receptor (galactose binding) |
|
Leprot |
1 |
0 |
leptin
receptor (similar) |
|
LOC383229 |
1 |
0 |
oxygen
binding |
|
Pmp22 |
1 |
75 |
myelin (peripheral) |
|
Leprotl1 |
1 |
112 |
leptin
receptor (similar) |
|
D430039N05Rik |
1 |
112 |
neuroreceptor
(rhodopsin like) |
|
Sorl1 |
2 |
150 |
LDL
receptor (vacuolar sorting) |
|
Fstl1 |
1 |
150 |
activin
binding |
|
Glra1 |
1 |
112‡ |
glycine
receptor widely distributed in CNS) |
|
Gpr37 |
1 |
187‡ |
neuroreceptor
(rhodopsin like) |
|
Adam23 |
1 |
262‡ |
integrin
ligand (possible neurogenesis) |
|
Total |
13 |
|
12
Unique Genes |
|
Table I -C Transport Protein Sequences |
|||
|
Gene Abbreviation |
Gene Frequency |
UniGene Frequency |
Putative and Known Functions |
|
Slc3a2 |
1 |
0 |
amino
acid transport |
|
Pdzk1 |
1 |
0 |
Phosphate
transport |
|
Rhoq |
1 |
0 |
glucose
uptake (insulin stimulated) |
|
Apol2 |
1 |
0 |
lipid
transport |
|
Hspa8 |
1 |
0 |
protein
folding |
|
Arl6ip1 |
1 |
0 |
protein
transport (possible) |
|
Dysf |
1 |
0 |
vesicle
fusion |
|
Flot2 |
3 |
37 |
glucose
uptake |
|
1a2 |
2 |
37 |
sodium
ion transport |
|
Gnai3 |
1 |
37 |
potassium
channel |
|
Vamp1 |
4 |
75 |
vesicle
fusion for transmission |
|
Kcnk1 |
1 |
75 |
potassium
channel |
|
Vps25 |
1 |
112 |
endosomal
sorting |
|
Slc6a5 |
4 |
150‡ |
glycine reuptake (myelin) |
|
Trf |
1 |
163 |
iron Transport (myelin) |
|
Stxbp1 |
2 |
187‡ |
vesicle
docking Ach release |
|
Nsf |
1 |
300 |
vesicle
fusion for transmission |
|
Kcnj10 |
1 |
225‡ |
potassium channel (myelin) |
|
ApoD |
1 |
412‡ |
lipid
transport |
|
Total |
29 |
|
19
Unique Genes |
|
Table I -D Regulatory Protein Sequences |
|||
|
Gene Abbreviation |
Gene Frequency |
UniGene Frequency |
Putative and Known Functions |
|
Sel1h |
1 |
[no data] |
negatively
modulates notch protein |
|
Moap1 |
1 |
0 |
apoptosis |
|
Rap1b |
1 |
0 |
axon
development |
|
Stat5b |
3 |
0 |
transcription
regulation |
|
Tspan7 |
1 |
0 |
neurite
outgrowth putative |
|
Rpl9 |
1 |
0 |
Ribosomal
RNA binding |
|
Dzip1 |
1 |
0 |
transcription
regulation |
|
Tcfcp2 |
1 |
37 |
Transcription
regulation |
|
Cstf2t |
1 |
37 |
transcription
regulation |
|
Krba1 |
1 |
75‡ |
transcription
regulation |
|
Hsp90b1 |
2 |
112 |
anti-apoptosis |
|
Atxn2 |
1 |
112 |
apoptosis |
|
Cdkn2d |
1 |
112‡ |
inhibits
cyclin dependent kinase 2 |
|
Calcb |
1 |
112‡ |
neuropeptide
activity |
|
Abat |
1 |
122 |
GABAase |
|
Cnot2 |
1 |
150 |
transcription
regulation |
|
Ncor1 |
1 |
150 |
transcription
regulation |
|
Ncdn |
1 |
150 |
bone
resorption |
|
Rpa1 |
1 |
187 |
DNA
binding |
|
Morf4l2 |
1 |
225 |
transcription
regulation |
|
Tbl1xr1 |
8 |
225‡ |
transcription
regulation |
|
Ndrg1 |
1 |
262 |
axon
survival |
|
Rtn3 |
1 |
262 |
neural
survival (co precipitates with Bace1) |
|
s100b |
4 |
262‡ |
neural survival (located in astrocytes) |
|
Hnrpf |
2 |
337‡ |
Heterogeneous nuclear RNA binding |
|
Total |
39 |
|
25 Unique Genes |
|
Table I -E Enzyme Sequences |
|||
|
Gene Abbreviation |
Gene Frequency |
UniGene Frequency |
Putative and Known Functions |
|
Lars2 |
26 |
0 |
Leucine
aminoacyl transferase (translation) |
|
Htatip |
1 |
0 |
acetyltransferase
histone (DNA repair) |
|
Pgam2 |
1 |
0 |
glycolysis |
|
Pld1 |
1 |
0 |
phospholipase |
|
Lonrf2 |
1 |
0 |
protease |
|
Stt3b |
1 |
0 |
transferase |
|
Rnf128 |
1 |
0 |
ubiquitin
ligase |
|
Plcb4 |
2 |
37 |
Phospholipase
C |
|
Ext1 |
1 |
37 |
glycosyl
transferase |
|
P4ha2 |
1 |
37 |
Prolyl
4-hydroxylase (collagen formation) |
|
Pdhx |
1 |
37 |
pyruvate
dehydrogenase (PDH) complex component X |
|
Pcmt1 |
2 |
75 |
methyltransferase
carboxyl (protein) |
|
Acsl5 |
1 |
75 |
acetyl
CoA synthetase (lipid metabolism) |
|
Pdha1 |
1 |
75 |
|
|
Pnpt1 |
1 |
75 |
RNA
processing |
|
Pgm2 |
2 |
112 |
glycolysis
phosphoglucomutase activity |
|
Mod1 |
1 |
112 |
glycolysis
Dehydrogenase malate |
|
Ndufs2 |
1 |
112 |
|
|
Aldoc |
3 |
150 |
glycolysis
aldolase 3, C isoform |
|
Tnks2 |
1 |
150 |
transferase
PARP activity |
|
Ube3a |
1 |
186 |
ubiquitin
protein ligase |
|
Scd2 |
1 |
487 |
Stearoyl-CoA
desaturase (lipid metabolism) |
|
Klk6 |
2 |
150‡ |
protease |
|
Fbxl2 |
1 |
300‡ |
ubiquitin
protein ligase activity |
|
Bcat1 |
1 |
450‡ |
transferase
amino |
|
Bace1 |
1 |
525‡ |
protease
APP (co precipitates with Rtn3) |
|
Nat8l |
2 |
825‡ |
acetytransferase
(drug metabolism) aka 1110038O08Rik |
|
Total |
59 |
|
27
Unique Genes |
|
Table I -F Hypothetical, Putative and Unknown Protein Sequences and
Novel Expressed Sequence Tags |
|||
|
Gene Abbreviation |
Gene Frequency |
UniGene Frequency |
Putative and Known Functions |
|
ES387449 |
1 |
[no data] |
Chromosome 10 or Mitochondrial rnp (on the
mitochondrial chromosome). Exhibits poly A therefore probably on chromosome 10
and not yet shown to be expressed i.e. no EST found in BLAST |
|
ES387454 |
1 |
[no data] |
Chromosome 8 (6402746-6403184) (new EST this
study) |
|
ES387457 |
1 |
[no data] |
Chromosome 11 (20826626-20826095) (one additional
EST #AW493294) |
|
ES387458 |
1 |
[no data] |
chromosome 1 (2145025-2145486)
or Mitochondrial chromosome (11164-10586) no ESTs found in BLAST |
|
1110001P04Rik |
1 |
0 |
Unclassifiable
(putative) |
|
B230209007 |
1 |
0 |
Unclassifiable
(hypothetical protein) |
|
D9Ertd402e |
1 |
0 |
Unknown
(hypothetical protein LOC382117) |
|
Armcx1 |
1 |
0 |
Unknown
(possible involvement in normal cell growth) |
|
Ahi1 |
1 |
0 |
Unknown (WD40 domain, found in a number of
eukaryotic
proteins that cover a wide variety of functions including
adaptor/regulatory modules in signal transduction,
pre-mRNA processing and cytoskeleton assembly) |
|
Brwd2 |
1 |
0 |
Unknown
(WDR11 is a candidate gene for the frequently proposed tumor suppressor
gene in 10q25-26 which is involved in tumorogenesis of glial and other tumors
showing frequent alterations in the distal 10q region) |
|
Dhcr24 |
1 |
0 |
Putative |
|
Ubxd4 |
1 |
0 |
Unknown
(hypothetical UBX domain containing protein) |
|
2610204L23Rik |
1 |
37 |
Hypothetical
protein |
|
4732416N19Rik |
2 |
37 |
Unclassifiable
(putative) |
|
Dctn6 |
1 |
37 |
Unknown
(putative mitochondria biogenesis) |
|
Golph3 |
2 |
37 |
Unknown
(putative trans Golgi protein) |
|
Slain1 |
1 |
37 |
unknown |
|
Rab11fip4 |
1 |
37 |
unknown |
|
Tspan4 |
1 |
37 |
Unknown
(complexes with integrins and possibly involved in cell development) |
|
1200009O22Rik |
1 |
75‡ |
transferase
(putative) |
|
Cyhr1 |
1 |
75 |
Unknown
(cystien and histidine rich protein 1) |
|
E430025E21Rik |
1 |
75 |
Unknown
(hypothetical protein LOC223593) |
|
|
|||
|
|
|||
|
|
|||
|
|
|||
|
Table I –F (cont.) Hypothetical, Putative and Unknown Protein Sequences and Novel
Expressed Sequence Tags |
|||
|
Wdr20a |
1 |
81 |
Unknown
(WD40 domain, found in a number of eukaryotic proteins that cover a wide
variety of functions including adaptor/regulatory modules
in signal transduction, pre-mRNA processing and
cytoskeleton assembly) |
|
Tmem85 |
1 |
112 |
Unknown
(hypothetical protein LOC68032) |
|
Sh3bp5l |
1 |
112 |
unknown |
|
B230380D07Rik |
1 |
122 |
Unknown
(hypothetical protein LOC235461) |
|
C030046I01Rik |
1 |
187 |
Unknown
(hypothetical protein, putative weakly similar to
HYPOTHETICAL 4.9 KDA PROTEIN |
|
Tnfrsf19l |
1 |
262‡ |
Unknown
(putative) |
|
Prpf19 |
1 |
337‡ |
Unknown
(possible splicesome activity, possible ds DNA repair) |
|
6330407J23Rik |
1 |
337‡ |
Unknown
(hypothetical protein LOC67412) |
|
6330527O06Rik |
4 |
412‡ |
Unknown
(possible glycolsylation related –LAMP protein) |
|
Total |
36 |
|
32
Unique Genes |
|
Listing of genes differentially
expressed in spinal cord following subtraction with myelin cDNA arranged by
UniGene frequency. 1.
UniGene refers to the estimated number of transcripts per million
listed for Mus musculus spinal cord as of March 31, 2007. 2.
(‡) indicates genes that are among the three highest transcripts per
million in spinal cord. |
TABLE II
GENES OF KNOWN GLIAL ORIGIN
DIFFERENTIALLY EXPRESSED
IN
SPINAL CORD VERSUS WHITE MATTER
|
Table II |
|||
|
Genes of Known Glial Cell Origin
Differentially Expressed in Spinal Cord Versus White Matter |
|||
|
Gene |
Colonies |
UniGene |
Specificity |
|
Slc6a5 |
4 |
150‡ |
Solute carrier family 6
(neurotransmitter transporter, glycine), member 5 |
|
Gfap |
3 |
112‡ |
glial fibrillary acidic protein |
|
Mpz |
3 |
0 |
myelin protein zero |
|
Plp1 |
2 |
712‡ |
proteolopid protein |
|
S100b |
2 |
262‡ |
S100 Calcium binding protein beta |
|
Trf |
1 |
163 |
transferrin |
|
Mbp |
1 |
2026‡ |
myelin basic protein |
|
Kcnj10 |
1 |
300‡ |
Inwardly rectifying calcium channel
subfamily J |
|
Pmp22 |
1 |
75 |
peripheral myelin protein 22 |
Note 1: Genes
underlined and in italics are also seen in subtractions using visual cortex as
driver and
spinal cord as tester (Lathia et al. 2006).
Note 2: UniGene
entries identified by ‡ signify genes that are expressed either first, second
or third
highest in spinal cord in Mus musculus.
TABLE III
GENE SEQUENCES
DIFFERENTIALLY EXPRESSED
IN
WHITE MATTER VERSUS SPINAL CORD
|
Table III Gene Sequences
Differentially Expressed in White Matter Versus Spinal Cord |
||
|
|
Colonies |
Specificity |
|
Ttr |
11 |
Retinol
binding (associated with amyloid disease) |
|
Rasd2* |
1 |
Cell communication
membrane protein GTPase activity |
|
Nos1ap |
1 |
Studies
of the related mouse and rat proteins have shown that this protein functions
as an adapter protein linking nNOS to specific targets, such as Dexras1 and
the synapsins. |
|
D3Bwg0562e |
1 |
peroxidase
activity |
|
Hpcal4 |
1 |
This
encoded protein may be involved in the calcium-dependent regulation of
rhodopsin phosphorylation. The transcript of this gene has multiple
polyadenylation sites |
|
Prkcb1 |
1 |
protein
kinase |
|
Txndc11 |
1 |
thioredoxin domain like 1 |
|
Zcchc12 |
1 |
Nucleotide
binding zinc finger |
|
Zmynd11 |
1 |
Nucleotide
binding zinc finger |
|
Atp2b1 |
1 |
Calcium
transport membrane protein |
|
Kcns2 |
1 |
Potassium
channel |
|
Itpr2 |
1 |
Inositol |
|
M6prbp1 |
1 |
Protein phosphate 1 |
|
Psd2 |
1 |
Pleckstrin and Sec7 domain
containing 2 |
|
Arpp-21 |
1 |
Cyclic AMP-regulated
phosphoprotein, 21 kD |
|
Dlgh4 |
1 |
scaffolding
protein that binds and clusters N-methyl-D-aspartate receptors at neuronal
synapses |
|
Novel ESTs |
|
|
|
Sub24-1rv2F7 |
1 |
|
|
Sub24-1rv2D8 |
1 |
|
Note.
Listing of genes represented in order of number of colonies observed. Novel expressed sequence
tags
have been submitted to the NCBI.
FIGURE 1
REPRESENTATIVE DOT BLOT ANALYSIS
Fig. 1 Representative dot blot analyses of four identical membranes
spotted with 1uL of PCR product from individual bacterial colonies transformed
with cDNA from forward suppression subtractive hybridization (SSH). Each membrane was subsequently hybridized
with the following probes:
Forward Subtracted signifies cDNA derived from spinal cord as tester
and white matter as driver
Forward Unsubtracted signifies cDNA derived from spinal cord before
subtraction against white matter.
Reverse Subtracted signifies cDNA derived from white matter as tester
and spinal cord as driver.
Reverse Unsubtracted signifies cDNA derived from white matter before
subtraction against spinal cord.
Clones are considered to be representative of cDNA sequences
differentially expressed only if the density of labeling in the forward
subtracted condition is at least twice that of any other condition.
FIGURE 2
REPRESENTATIVE NORTHERN ANALYSIS
Fig. 2 Northern blot analysis of total RNA from 90-110-day-old C57Bl6J
male mice hybridized with radiolabeled probes.
The genes were selected from three categories according to their level
of expression as recorded in the UniGene database.
The samples were normalized with β-actin as represented in the
figure. Lanes in the figure are as
follows: SC represents spinal cord; WM
represents white matter. Spinal cord is
the tester and white matter is the driver in the study.